Dividend stocks are a great source of passive income. For those who opt to reinvest their dividends, the move can substantially boost returns over the long run. And while top income stocks often attract plenty of attention from eager investors who bid up their share prices, it's possible to find some that have been punished by the market -- perhaps because of company-specific issues -- that are still worth buying.

Let's consider two notable examples today: Gilead Sciences (NASDAQ: GILD) and eBay (NASDAQ: EBAY). Here's the rundown on these two solid but beaten-down, dividend-paying companies.

Gilead Sciences' financial results have been impressive over the past few years as the biotech dealt with fluctuating revenue from its COVID-19 therapy, Veklury. In some sense, Veklury has been a lifesaver for Gilead Sciences. It was one of the first therapies authorized to treat COVID-19, and even with new variants of the virus, it remains in use. It helped the drugmaker's revenue stay afloat while sales of other products dropped due to the outbreak.

Continue reading

Source Fool.com